Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • 100,000 Genomes Project Reaches Halfway Milestone

    Bio-IT World Brief | The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes.

    Feb 20, 2018
  • Doctors Said Immunotherapy Would Not Cure Her Cancer. They Were Wrong.

    The New York Times | Scientists are racing to understand why immunotherapy drugs have worked for a few cancer patients when the medicines should have had no effect.

    Feb 19, 2018
  • Cambridge Semantics Announces Graph-Based Online Analytics Support For Amazon Neptune, Graph Databases

    Bio-IT World Brief | Cambridge Semantics announced a preview of AnzoGraph, a native graph-based parallel query engine available for analyzing data from Amazon Neptune, the new fully managed graph database service from Amazon Web Services.

    Feb 16, 2018
  • iRODS Consortium Carries Open Source Data Management Software Forward

    Bio-IT World | Integrated Rule-Oriented Data System is used across the globe in industries ranging from the life and physical sciences to media and entertainment. Recent developments in the software have invigorated the life sciences community and provided the possibility of collaboration.

    Feb 15, 2018
  • Bristol-Myers To Pay Largest Fee In Biotech History For Nektar Cancer Drug

    Forbes | Bristol-Myers Squibb says it will pay a record $1.85 billion to Nektar Therapeutics, a small biotech startup, for rights to its experimental cancer drug, codenamed NKTR-214. Nektar will book 65% of global profits on the drug, should it reach the market, with Bristol getting the other 35%.

    Feb 14, 2018
  • The Pistoia Alliance Launches User Experience For Life Sciences Toolkit

    Bio-IT World Brief | The Pistoia Alliance has today announced the launch of the User Experience for Life Sciences Toolkit, to help life science companies improve UX in line with other global industries.

    Feb 13, 2018
  • «
  • 321 (current)
  • 322
  • 323
  • 324
  • 325
  • 326
  • 327
  • 328
  • 329
  • 330
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy